RxDoctor Payments Data

Chia-Shi Wang, MD

Pediatric Nephrology · Atlanta, GANPI 1730323346

Payments from drug & device makers

What this record shows

This record is dominated by education: $4 of the $4 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Travere Therapeutics, Inc..

$4in general payments, 2019–2025

Across 1 payment — averaging $3.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Travere Therapeutics, Inc.$4
$277,998in research payments, 2019–2025

Across 25 payments — averaging $11,120 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$183K
  • Hoffmann-la Roche Limited$92K
  • Boehringer Ingelheim International GmbH$3K

What the payments were for

  • Education$4100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Travere Therapeutics, Inc.1$4

How this compares

Too few pediatric nephrology providers in Georgiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$6,453
Medicare patients
19
Services billed
54

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pediatric nephrology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →